Abstract:Here, we present combined experimental and theoretical studies on the spectroelectrochemical properties of 8-aminoquinoline (8AQ). 8AQ is a model molecule for drugs that can chelate copper(II) ions, and thus it may find applications in halting the development of Alzheimer’s disease. Although over a hundred years have passed since Alzheimer’s disease (AD) was first described, it remains incurable to this day. According to one of the leading hypotheses, peptides from the β-amyloid (Aβ) group are responsible for the development of AD. By binding copper(II) ions, Aβs form complexes whose presence promotes the formation of harmful, highly active compounds called reactive oxygen species (ROS) and reactive nitrogen species (RNS). In a series of recent studies, we investigated the differences in electrochemical properties of Cu(II)-complexes with the amyloids Aβ(11-16) and Aβ(3-16) with their pyroglutamated versions, pAβ(11-16) and pAβ(3-16). [1,2] These results showed that the pyroglutamate amyloids are conducive to Cu(II)-reduction at a potential associated with ROS production. Given the abundance of pyroglutamated amyloids in senile plaques, this could have important consequences for AD pathophysiology. Overproduction of ROS and RNS can cause neuron death. Therefore, substances that can aid in removing copper(II) ions from β-amyloids could block the formation of ROS and RNS. Recently, a new quinoline derivative with unique properties has undergone preclinical studies. However, little is known about the redox properties of such molecules, which may be crucial in the early stages of testing potential therapeutic substances. Therefore, we aimed to perform electrochemical and spectroelectrochemical studies of a model molecule, 8-aminoquinoline, whose redox properties were not yet well characterized To fully characterize both anodic and cathodic processes, we used cyclic and pulse voltammetry over a wide range of pH values, including physiological (pH=7.4). In addition, the experimental results were supported by DFT-based computational studies exploring the energy landscapes of the possible reactions and advancing understanding of the electrochemical phenomena. The kind of electrochemical tests presented here may prove of crucial importance for the development of more effective drugs against AD. The high failure rate and relatively poor performance of the recently approved treatment indicates the need to extend preclinical studies with new, so far unused techniques, allowing a more complete picture to be obtained of the effectiveness and toxicity of the potential drug candidates. [1] M.Z. Wiloch, N. Baran, M. Jönsson‐Niedziółka, The Influence of Coordination Mode on the Redox Properties of Copper Complexes with Aβ(3‐16) and Its Pyroglutamate Counterpart pAβ(3‐16), ChemElectroChem. 9 (2022). https://doi.org/10.1002/celc.202200623. [2] M.Z. Wiloch, M. Jönsson-Niedziółka, Very small changes in the peptide sequence alter the redox properties of Aβ(11–16)-Cu(II) and pAβ(11–16)-Cu(II) β-amyloid complexes, Journal of Electroanalytical Chemistry. 922 (2022) 116746. https://doi.org/10.1016/j.jelechem.2022.116746.

Ionophoric polyphenols selectively bind Cu(2+), display potent antioxidant and anti-amyloidogenic properties, and are non-toxic toward Tetrahymena thermophila

Design, Synthesis and Biological Evaluation of 2-Styryl-5-hydroxy-4-pyrone Derivatives and Analogues As Multiple Functional Agents with the Potential for the Treatment of Alzheimer's Disease.

Synthesis and Biological Evaluation of Deferiprone-Resveratrol Hybrids As Antioxidants, Aβ1–42 Aggregation Inhibitors and Metal-Chelating Agents for Alzheimer's Disease

The RAIN Project and First Results from Eilandvlei and Verlorenvlei

Novel 1-phenyl-3-hydroxy-4-pyridinone derivatives as Multifunctional Agents for the therapy of Alzheimer's Disease.

Polyphenols as Potential Metal Chelation Compounds Against Alzheimer's Disease

Spectroelectrochemical and Computational Study of Quinoline Based Molecules - Potential Anti-Alzheimer’s Drugs

A multifunctional anti-AD approach: Design, synthesis, X-ray crystal structure, biological evaluation and molecular docking of chrysin derivatives

Identification of N-phenyl-3-methoxy-4-pyridinones As Orally Bioavailable H3 Receptor Antagonists and Β-Amyloid Aggregation Inhibitors for the Treatment of Alzheimer's Disease.

Evaluation of Anti‐Alzheimer's Potential of Azo‐Stilbene‐Thioflavin‐T derived Multifunctional Molecules: Synthesis, Metal and Aβ Species Binding and Cholinesterase Activity

Synthesis and bio-activities of bifunctional tetrahydrosalen Cu (II) chelators with potential efficacy in Alzheimer's disease therapy

Novel coumarin derivatives as multifunctional anti-AD agents: Design, synthesis, X-ray crystal structure and biological evaluation

Bifunctional Copper Chelators Capable of Reducing Aβ Aggregation and Aβ-Induced Oxidative Stress

The impact of chelating compounds on Cu2+, Fe2+/3+, and Zn2+ ions in Alzheimer's disease treatment

A cocktail of Cu 2+ - and Zn 2+ -peptoid-based chelators can stop ROS formation for Alzheimer's disease therapy

Evaluation of Anti-Alzheimer’s Potential of Azo-Stilbene-Thioflavin-T derived Multifunctional Molecules: Synthesis, Metal and Abeta Species Binding and Cholinesterase Activity

Effects of Cyclen and Cyclam on Zinc(ii)- and Copper(ii)-Induced Amyloid Beta-Peptide Aggregation and Neurotoxicity.

Next-generation Cu(II) selective peptide shuttles prevent Cu(Aβ)-induced toxicity and microglial activation in organotypic hippocampal slices

Study on the novel usnic acid derivatives: Design, synthesis, X-Ray crystal structure of Cu(II) complex and anti-AD activities

Dihydropyrimidine-Thiones and Clioquinol Synergize To Target β-Amyloid Cellular Pathologies through a Metal-Dependent Mechanism

Understanding the Molecular Mechanisms of Polyphenol Inhibition of Amyloid β Aggregation